First Approved Treatment for Generalized Pustular Psoriasis

(MedPage Today) -- The FDA has approved the monoclonal antibody spesolimab (Spevigo) as the first treatment for generalized pustular psoriasis (GPP), Boehringer Ingelheim announced. The approval stipulates use of the drug to treat GPP flares in...
Source: MedPage Today Public Health - Category: American Health Source Type: news